Three cases of reversible agranulocytosis after treatment with lamotrigine

Psychiatry Investigation

Volumn 5, Issue 2, 2008, Pages 121-123

  Ahn, Yong Min ^a   Kim, Kunjong ^a   Kim, Yong Sik ^a  

^a Seoul National University   (South Korea)

Author keywords

Agranulocytosis; Bipolar disorder; Lamotrigine

Indexed keywords

AMISULPRIDE; ANTICONVULSIVE AGENT; CLOZAPINE; FLUOXETINE; GRANULOCYTE COLONY STIMULATING FACTOR; LAMOTRIGINE; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISPERIDONE; TRAZODONE; VALPROIC ACID;

ADULT; AGRANULOCYTOSIS; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; NEUTROPENIA; PATHOPHYSIOLOGY;

EID: 46949103493     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2008.5.2.121     Document Type: Article

References (12)

1. GlaxoSmithKline Inc. Lamictal® (lamotrigine) product monograph. Missassauga, ON: glaxoSmithKline Inc; 2001.
2. Nicholson RJ, Kelly KP, Grant IS. Leucopenia associated with lamotrigine. BMJ 1995;310:504.
3. de Carmago OA, Bode H. Agranulocytosis associated with lamotrigine. BMJ 1999;318:1179.
4. Solvason HB. Agranulocytosis associated with lamotrigine. Am J Psychiatry 2000;157:1704.
5. Fadul CE, Meyer LP, Jobst BC, Cornell CJ, Lewis LD. Agranulocytosis associated with lamotrigine in a patient with low-grade glioma. Epilepsia 2002;43:199-200.
6. Lu W, Uetrecht JP. Possible bioactivation pathways of lamotrigine. Drug Metab Dispos 2007;35:1050-1056.
7. Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, et al. Treatment of bipolar disorder: a complex treatment for a multifacet disorder. Ann Gen Psychiatry 2007;6:27.
8. Sedky K, Lippmann S. Psychotropic medications and leukopenia. Curr Drug Targets 2006;7:1191-1194.
9. Alvir JM, Liebcrman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl .1 Med 1993;329:162-167.
10. LeDrew K, Phillips L, Hogan M, MacCallum A. Lamotrigine induced neutropenia. Can J Psychiatry 2005;50:242.
11. Damiani JT, Christensen RC. Lamotrigine-associated neutropenia in a geriatric patient. Am J Geriatr Psychiatry 2000;8:346.
12. Ahn YM, Jeong SH, Jang HS, Koo YJ, Kang UG, Lee KY, et al. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results. Int Clin Psychopharmacol 2004;19:97-101.